Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?

Mark W Kennedy1,2, Enrico Fabris1,2, Harry Suryapranata1,2

  • 1Isala Hartcentrum, Docter van Heesweg 2, Zwolle, The Netherlands.

Insights

Diabetes mellitus (DM) patients with coronary atherosclerosis may face high cardiac event risk even without ischemia. This review questions if factors beyond ischemia are crucial for risk stratification in these patients.

Area of Science:

  • Cardiology
  • Diabetology
  • Vascular Biology

Background:

  • Diabetes mellitus (DM) significantly increases cardiovascular morbidity and mortality, with higher rates of coronary artery disease.
  • Atherosclerosis in DM patients progresses faster and is more complex than in non-DM individuals.
  • Ischemia is a primary predictor of cardiac events, guiding revascularization strategies.

Purpose of the Study:

  • To review evidence for ischemia-driven revascularization in DM patients.
  • To challenge the sole reliance on ischemia for cardiovascular risk prediction in DM.
  • To explore if factors beyond ischemia, like microvascular disease and plaque characteristics, are vital for risk stratification.

Main Methods:

  • Literature review of current evidence on revascularization strategies in DM.
  • Analysis of studies investigating cardiovascular outcomes in DM patients with and without ischemia.
  • Examination of factors beyond ischemia, including atherosclerosis burden, progression, and plaque composition.

Main Results:

  • Recent data suggest DM patients with coronary atherosclerosis may have elevated cardiac event risk, even without detectable ischemia.
  • The predictive value of ischemia alone for cardiac events in DM patients is questioned.
  • Non-ischemic factors may influence cardiovascular outcomes in DM.

Conclusions:

  • Ischemia may not be the only critical factor for predicting cardiovascular outcomes in all DM patients.
  • Microvascular disease, atherosclerosis burden, progression, and plaque composition warrant consideration for refined risk stratification.
  • A comprehensive approach beyond ischemia is needed for managing cardiovascular risk in DM.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
537
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K